Journal Home
Search for

Volume 27, Issue 10, Pages 1309-1318 (December 2009)


View previous. 3 of 16 View next.

MRI-based biomechanical imaging: initial study on early plaque progression and vessel remodeling

Jie ZhengaCorresponding Author Informationemail address, Dana R. Abendscheina, Ruth J. Okamotoa, Deshan Yanga, Kyle S. McCommisa, Bernd Misselwitzb, Robert J. Groplera, Dalin Tangc

Received 29 November 2008; received in revised form 2 March 2009; accepted 7 May 2009. published online 26 June 2009.

Abstract 

The goal of the study is to develop a noninvasive magnetic resonance imaging (MRI)-based biomechanical imaging technique to address biomechanical pathways of atherosclerotic progression and regression in vivo using a 3D fluid-structure interaction (FSI) model. Initial in vivo study was carried out in an early plaque model in pigs that underwent balloon-overstretch injury to the left carotid arteries. Consecutive MRI scans were performed while the pigs were maintained on high cholesterol (progression) or normal chow (regression), with an injection of a plaque-targeted contrast agent, Gadofluorine M. At the end of study, the specimens of carotid arterial segments were dissected and underwent dedicated mechanical testing to determine their material properties. 3D FSI computational model was applied to calculate structure stress and strain distribution. The plaque structure resembles early plaque with thickened intima. Lower maximal flow shear stress correlates with the growth of plaque volume during progression, but not during regression. In contrast, maximal principle structure stress/stain (stress-P1 and strain-P1) were shown to correlate strongly with the change in the plaque dimension during regression, but moderately during progression. This MRI-based biomechanical imaging method may allow for noninvasive dynamic assessment of local hemodynamic forces on the development of atherosclerotic plaques in vivo.

a Mallinckrodt Institute of Radiology, Washington University, St. Louis, MO 63131, USA

b Bayer Schering Pharma AG, 13353 Berlin, Germany

c Worcester Polytechnic Institute, MA 01609, USA

Corresponding Author InformationCorresponding author. Mallinckrodt Institute of Radiology, Washington University School of Medicine, Box 8225, St. Louis, MO 63110, USA. Tel.: +1 314 747 4608; fax: +1 314 747 3882.

PII: S0730-725X(09)00119-2

doi:10.1016/j.mri.2009.05.032


View previous. 3 of 16 View next.